The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma.
 
Neha Mehta-Shah
No Relationships to Disclose
 
Matthew Alexander Lunning
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Onyx; Spectrum Pharmaceuticals; TG Therapeutics
 
Adam M. Boruchov
Speakers' Bureau - Celgene; Takeda
 
Jia Ruan
Consulting or Advisory Role - Celgene
Speakers' Bureau - Celgene
Research Funding - Celgene
 
Sumithra Nair
No Relationships to Disclose
 
Peggy Lynch
No Relationships to Disclose
 
Regina Byrne
No Relationships to Disclose
 
Alison J. Moskowitz
Consulting or Advisory Role - Merck; Seagen
Research Funding - Seagen
 
Matthew J. Matasar
No Relationships to Disclose
 
John F. Gerecitano
No Relationships to Disclose
 
Paul A. Hamlin
Honoraria - Genentech/Roche
Consulting or Advisory Role - Gilead Sciences; Pfizer
Research Funding - GlaxoSmithKline (Inst); Janssen (Inst); molecular templates (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)
 
John Leonard
Consulting or Advisory Role - Celgene
 
Craig H. Moskowitz
No Relationships to Disclose
 
Patricia L. Myskowski
No Relationships to Disclose
 
Christiane Querfeld
Consulting or Advisory Role - Actelion; Celgene
 
Patrick Nolan
No Relationships to Disclose
 
Maria Lia Palomba
Consulting or Advisory Role - Pharmacyclics
 
David J. Straus
No Relationships to Disclose
 
Andrew David Zelenetz
Honoraria - Celgene; Gilead Sciences
Consulting or Advisory Role - Alissa Pharma; Amgen; Dr. Reddy's Laboratories; Genentech/Roche; Gilead Sciences; Hospira
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Kirin Pharmaceuticals
Other Relationship - Boehringer Ingelheim
 
Steven M. Horwitz
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium
Research Funding - Celgene; Infinity Pharmaceuticals; Kirin Pharmaceuticals; Millennium; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - ADC Therapeutics; Infinity Pharmaceuticals; Janssen; RAND Corporation